FDA Approval Activities for this Drug…

Infasurf (calfactant) Intratracheal Suspension, ONY NDA 20-521 7/1/1998 7/2/98 7/2/98 4/11/02 Infasurf Indication: for the prevention and treatment of Respiratory Distress Syndrome (RDS) in neonates.

For the latest approval information, please locate this drug using this index.